Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Quinacrine does not extend survival in sporadic Creutzfeldt-Jakob disease

April 21, 2010

Data on vipadenant warrant further development in moderate- to late-stage PD patients

April 21, 2010

MTD of EMD-534085 established in phase I trial in advanced solid tumors and lymphoma

April 20, 2010

Phase Ib safety/efficacy data disclosed on SD-101 in treatment-naive hepatitis C

April 20, 2010

Fab-001 potently active against multiple staphylococcal strains in preclinical study

April 20, 2010

Phase II/III data on tafamidis meglumine in TTR-type familial amyloid polyneuropathy

April 20, 2010

Phase III data presented on sodium oxybate in fibromyalgia

April 20, 2010

Updated phase I data presented on JI-101 in solid tumors

April 19, 2010

Studies on progesterone caproate for prevention of preterm birth

April 19, 2010

Mirabegron well tolerated and improves overactive bladder variables in large study

April 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...